维普中文期刊产品整合服务
47篇 您的检索式:作者名="Agerso"
    题名 作者 年代 出处 被引量
1Comparison of anti- microbial resistance phenotypes and resistance genes in Enterococ- cns faecalis and Enterococcus faecium from humans in the commu- nity, broilers, and pigs in Denmark 显示文摘Aarestrup FM Agerso Y Gemer-Smidt P 2000Diagn Microbiol Infect Dis2000,37,2:1
2Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcusfaecalis and Enterococcusfaecium from humans in the community,broilers,and pigs in Denmark显示文摘AARESTRUP F M AGERSO Y GERNER-SMIDT P 2000Diagnostic Microbiology and Infectious Disease2000,37,:1
3Laboratory and projectbased learning in the compulsory course Biological Chemistry enhancing collaboration and technical communication between groups 显示文摘Agerso Y Bysted A Jensen LB 20117th International CDIO Conference2011,,:1
4The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men 显示文摘AGERSO H JENSEN L B ELBROND B 2002Diabetologia2002,45,2:1
5Bacterial antibiotic resistance levels in Danish farmland as a result of treatment with pig manure slurry显示文摘Sengel(o)v G Agerso Y Halling-S(o)rensen B 0,,07:1
6Pharmacokinetics pharmacodybnamics, and safety of a novel fact-acting gonadotropin-releasing hormoue receptor blocker, degarelix, in healthy men显示文摘Balchen T Agerso H Olesen TK Presented at:8th International Symposium on GnRH Analogues in cancer and Human Reproduction Salzburg Audtria 200 50,4,:1
7Bacterial antibiotic resistance levels in Danish farmland as a result of treatment with pig manure slurry显示文摘Sengelov G Agerso Y Halling-Sorensen B 2003Environ Int2003,28,:1
8The pharmacokinetics,pharmacodynamics,safety and tolerability of NN211,a new long-acting GLP-1 derivative,in healthy men显示文摘Agerso H Jensen LB Elbrond B 2002Diabetologia2002,45,2:1
9The pharmacokinetics,pharmacodynamics,safety and tolerability of NN2211,a new long-acting GLP-1 derivative,in healthy men显示文摘Agerso H Jensen LB Elbrond B 2002Diabetologia2002,45,2:1
10Bioavailability of amoxycinin in pigs显示文摘H Agerso C Friis 1998J Vet Pharmacol Ther1998,21,1:1
11The elimination rates of intact GIP as well as its primary metabolite,GIP 3-42,are similar in type 2 diabetic patients and healthy subjects显示文摘Vilsboll T Agerso H Lauritsen T et a1 2006Regulatory Peptides2006,137,3:1
12Bioavailability of amoxycillin in pigs显示文摘Agerso H Friis C 1998Journal of Veterinary Pharmacology and Therapeutics1998,21,:1
13Similar elimination rates of glucagon-like peptide 1 in obese type 2 diabetes patients and healthy subjects显示文摘Vilsboll T Agerso H Krarup T 2003J Clin Endocrinol Metab2003,88,1:1
14The phar- macokinetics, pharmacodynamics, safety and toler- ability of NN2211, a new long-acting GLP-1 deriva- tive, in healthy men显示文摘Agerso H Jensen L Elbrond B 2002Diabetologia2002,45,2:1
15Structure-activity and protraction relationship of long-acting glucagon-like peptide-1显示文摘Madsen K Knudsen LB Agersoe H 2007J Med Chem2007,50,24:1
16The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men显示文摘Agerso H Jensen L Elbrond B 2002Diabetologia2002,45,2:1
17First description of blaCTX-M-1-carrying Escherichia coli isolates in Danish primary food production显示文摘Aarestrup F M Hasman H Agerso Y 2006J Antimicrob Chemother2006,57,6:1
18Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark 显示文摘Aarestrup F M Agerso Y Gerner-Smidt P 2000Diagn Microbiol Infect Dis2000,37,2:1
19Bacterial antibiotic resistance levels in Danish farmland as a result of treatment with pig manure slurry 显示文摘Sengelov G Agerso Y Hailing - orensen B 2003Environ Int2003,28,:1
20The pharmaco- kinetics, pharmacodynamico, safety and tolerability of NN2211, a new long-acting GLP-I derivative, in healthy men显示文摘AGERSO H JENSEN L B ELBROND B 2002Diabe- tologia2002,45,2:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费